SHL TELEMEDICINE SP. ADR Logo
US78423T2006

SHL TELEMEDICINE SP. ADR

Ins Portfolio
Kostengünstig und breit gestreut in Europa investieren. Jetzt entdecken
Anzeige

Kurse werden geladen...

Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News


  • DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care

    NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced an expanded partnership with SHL Telemedicine (NASDAQ: SHLT) to integrate the SmartHeart® portable 12-lead ECG device across DocGo mobile health care units. This expanded collaboration, initially launched in the New York-New Jersey area, will now bring advanced cardiovascular diagnostics to patients' homes and underserved communities i.» Mehr auf businesswire.com


  • SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity

    TEL AVIV & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, has clarified today that it is in discussions with Discount Capital Ltd. the investment arm of Israel Discount Bank, regarding a possible investment relating to SHL's Israeli activity. At this point, the parties have not yet taken any decision nor entered into any binding obligation with regard to.» Mehr auf businesswire.com


  • SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test

    TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)---- $SHLT--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is proud to announce that it has expanded its offering in Israel to include the groundbreaking ability to perform at-home Biomarker blood tests. This diagnostic tool is designed to rapidly identify cardiac markers for detection of a heart attack, transforming emergency cardiac care with sp.» Mehr auf businesswire.com

Unternehmenszahlen

Im letzten Quartal hatte SHL TELEMEDICINE SP. ADR einen Umsatz von +12,98 Mio und ein Nettoeinkommen von 1,86 Mio
(EUR)Juni 2024
YOY
Umsatz+12,98 Mio-
Bruttoeinkommen+6,10 Mio-
Nettoeinkommen1,86 Mio-
EBITDA96,41k-

Fundamentaldaten

MetrikWert
Marktkapitalisierung
+28,53 Mio
Anzahl Aktien
16,39 Mio
52 Wochen-Hoch/Tief
+5,08 - +1,57
DividendenNein
Beta
0,29
KGV (PE Ratio)
8,54
KGWV (PEG Ratio)
2,82
KBV (PB Ratio)
+0,51
KUV (PS Ratio)
+1,21

Unternehmensprofil

Name
SHL TELEMEDICINE SP. ADR
CEO
David Arnon
Mitarbeiter583

Ticker Symbole

BörseSymbol
NASDAQ
SHLT
🍪

Parqet nutzt Cookies.Erfahre Mehr